How much do paid clinical trials in Ogden pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Ogden?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

How do I join a study in Ogden, UT?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

How often do new paid studies open in Ogden?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Ogden.

Paid Clinical Trials Ogden, UT — 117 Studies Recruiting (Jul 2026)

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis Phase 3 Interventional 400 participants sought

Baxis Site 17 — Layton, Utah (11.6 mi) · Sponsor: Baxis Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06911424)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 140 participants sought

Care Access-Ogden — Ogden, Utah (0.4 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06598943)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine Phase 3 Interventional 450 participants sought

Alpine Research Organization - Clinton /ID# 276497 — Clinton, Utah (7.4 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT05711394)

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

Graves Disease Phase 3 Interventional 300 participants sought

Site-013 — Layton, Utah (11.6 mi) · Sponsor: Biohaven Therapeutics Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07661056)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought

Research Site — Clearfield, Utah (8.6 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06883305)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 150 participants sought

Community Cancer Trials Of Utah /ID# 276598 — Ogden, Utah (0.4 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06568939)

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Asthma Phase 3 Interventional 724 participants sought

Teva Investigational Site 12153 — South Ogden, Utah (2.5 mi) · Sponsor: Teva Branded Pharmaceutical Products R&D LLC

See eligibility & contact on ClinicalTrials.gov (NCT06664619)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought

Research Site — Ogden, Utah (0.4 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT05774951)

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Pneumococcal Immunization, Healthy Volunteers Phase 3 Interventional 2,195 participants sought

Rio Clinical Trials - Canyon View- Site Number : 8400031 — Ogden, Utah (0.4 mi) · Sponsor: Sanofi

See eligibility & contact on ClinicalTrials.gov (NCT07348692)

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Crohn's Disease Phase 2 Interventional 99 participants sought

Investigational Site Number: 8400016 — Ogden, Utah (0.4 mi) · Sponsor: Sanofi

See eligibility & contact on ClinicalTrials.gov (NCT06958536)

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Correction Vision Surgery, Cataract Surgery N/A Observational 35 participants sought

Utah Eye Centers — Ogden, Utah (0.4 mi) · Sponsor: Utah Eye Centers

See eligibility & contact on ClinicalTrials.gov (NCT06924944)

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Asthma Phase 2 Interventional 540 participants sought

Research Site — Roy, Utah (5.5 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06932263)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

McKay-Dee Hospital Center — Ogden, Utah (0.4 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Overweight, Obesity Phase 3 Interventional 460 participants sought

AMR Clinical — Layton, Utah (11.6 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07253285)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought

Farmington Health Center — Farmington, Utah (17.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought

Akero Clinical Study Site — Ogden, Utah (0.4 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought

Alpine Research Association- Site Number : 8400050 — Layton, Utah (11.6 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company

See eligibility & contact on ClinicalTrials.gov (NCT06316297)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought

Farmington Health Center — Farmington, Utah (17.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04402788)

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Colon Adenocarcinoma, Rectal Adenocarcinoma Phase 3 Interventional 477 participants sought

Community Cancer Trials of Utah ( Site 0086) — Ogden, Utah (0.4 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06997497)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought

Galderma Investigational Site 7085 — Bountiful, Utah (23.8 mi) · Sponsor: Galderma R&D

See eligibility & contact on ClinicalTrials.gov (NCT06988605)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought

Ogden Regional Cancer Center — Ogden, Utah (0.4 mi) · Sponsor: Agendia

See eligibility & contact on ClinicalTrials.gov (NCT03053193)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought

Farmington Health Center — Farmington, Utah (17.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06876714)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a) Phase 3 Interventional 5,700 participants sought

Progressive Clinical Research — Bountiful, Utah (23.8 mi) · Sponsor: Novartis Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07517263)

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Obesity and Overweight Phase 3 Interventional 3,501 participants sought

Pantheon Clinical Research — Bountiful, Utah (23.8 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT07311850)

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Chronic Idiopathic Constipation (CIC) Phase 3 Interventional 692 participants sought

Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi) · Sponsor: Ardelyx

See eligibility & contact on ClinicalTrials.gov (NCT07382167)

Paid Clinical Trials in Ogden, UT

Studies recruiting near Ogden right now

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Top-rated research centers in Ogden

RIO Clinical Trials Canyon View

Advanced Research Institute-Ogden

RIO Clinical Trials Allen-Tainter

Community Cancer Trials of Utah, LLC

AMR Clinical

Progressive Clinical Research

Pantheon Clinical Research

CenExel Salt Lake City UT

Advanced Research Institute-Sandy

Clinical trials in Ogden: what's recruiting

How to enroll in a paid study in Ogden

Frequently asked questions

Paid clinical trials near Ogden

More of UT

New paid studies open every week